FDA Adverse Event Malfunction Summary report: N

ORTHO SERA ANTI-FYB

MDR report key: 18189734 · Received November 22, 2023

Report

Report Number
3011683976-2023-00015
Event Type
Malfunction
Date Received
November 22, 2023
Date of Event
October 27, 2023
Report Date
September 30, 2024
Manufacturer
ALBA BIOSCIENCE LIMITED (LTD.)
Product Code
QHT
PMA / PMN Number
125342
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
FR
Reporter Occupation
003

Narratives

Additional Manufacturer Narrative · 0

FOLLOW UP 01 OF 3011683976-2023-00015.

Additional Manufacturer Narrative · 0

H3 - OTHER - INVESTIGATION PERFORMED ON RETAINED SAMPLE FROM THE SAME BATCH. INTERNAL INVESTIGATION CONSISTED OF BOTH BATCH MANUFACTURING RECORD (BMR) REVIEWS AND INVESTIGATIVE TESTING. OUR INVESTIGATION HAS CONFIRMED THAT ORTHO¿ SERA ANTI-FYB PRODUCT FD153M LOT V254104 TO BE FIT FOR PURPOSE THEREFORE THIS COMPLAINT IS NOT CONFIRMED ALBA BIOSICENCE REFERENCE NUMBER OF THIS FILE IS (B)(4).

Description of Event or Problem · 0

CUSTOMER HAS REPORTED A FALSE POSITIVE FOR ORTHO SERA ANTI-FYB, PRODUCT FD153M LOT V254104, EXPIRY 28-DEC-24 IN COMBINATION WITH MULTIPLE LOTS OF MTS ANTI-IGG GEL CARDS WHEN TESTING ONE PATIENT SAMPLE AND THREE DONOR SAMPLES ON THEIR ORTHO VISION ANALYZERS.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
917739 ORTHO SERA ANTI-FYB REAGENT RED BLOOD CELLS QHT ALBA BIOSCIENCE LIMITED (LTD.) FD153M V254104

Patients

Seq Age Sex Outcome Treatment
1 NA Unknown